{"id":"https://openalex.org/W2093934591","doi":"https://doi.org/10.1161/01.cir.98.19.2037","title":"Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension","display_name":"Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension","alternate_titles":[],"publication_year":1998,"publication_date":"1998-11-10","ids":{"openalex":"https://openalex.org/W2093934591","doi":"https://doi.org/10.1161/01.cir.98.19.2037","mag":"2093934591","pmid":"https://pubmed.ncbi.nlm.nih.gov/9808602"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.98.19.2037","doi":"https://doi.org/10.1161/01.cir.98.19.2037","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.98.19.2037","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2093934591"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083818851","display_name":"Petra Th\u00fcrmann","orcid":"https://orcid.org/0000-0001-9724-1422","observed_orcids":["https://orcid.org/0000-0001-9724-1422"]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]},{"id":"https://openalex.org/I4210132578","display_name":"University Hospital Frankfurt","ror":"https://ror.org/03f6n9m15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132578"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Petra A. Thu\u0308rmann","raw_affiliation_strings":["From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","General Practice, Offenbach/Main (A.S.), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","institution_ids":["https://openalex.org/I155976169","https://openalex.org/I4210132578"]},{"raw_affiliation_string":"Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","institution_ids":[]},{"raw_affiliation_string":"General Practice, Offenbach/Main (A.S.), Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041531835","display_name":"Peter Kenedi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]},{"id":"https://openalex.org/I4210132578","display_name":"University Hospital Frankfurt","ror":"https://ror.org/03f6n9m15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132578"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Kenedi","raw_affiliation_strings":["From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","General Practice, Offenbach/Main (A.S.), Germany","Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","institution_ids":["https://openalex.org/I155976169","https://openalex.org/I4210132578"]},{"raw_affiliation_string":"Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","institution_ids":[]},{"raw_affiliation_string":"General Practice, Offenbach/Main (A.S.), Germany","institution_ids":[]},{"raw_affiliation_string":"Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)","institution_ids":["https://openalex.org/I4210132578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103573201","display_name":"Andor Schmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]},{"id":"https://openalex.org/I4210132578","display_name":"University Hospital Frankfurt","ror":"https://ror.org/03f6n9m15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132578"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andor Schmidt","raw_affiliation_strings":["From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","General Practice, Offenbach/Main (A.S.), Germany","Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","institution_ids":["https://openalex.org/I155976169","https://openalex.org/I4210132578"]},{"raw_affiliation_string":"Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","institution_ids":[]},{"raw_affiliation_string":"General Practice, Offenbach/Main (A.S.), Germany","institution_ids":[]},{"raw_affiliation_string":"Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)","institution_ids":["https://openalex.org/I4210132578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109139051","display_name":"Sebastian Harder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]},{"id":"https://openalex.org/I4210132578","display_name":"University Hospital Frankfurt","ror":"https://ror.org/03f6n9m15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132578"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sebastian Harder","raw_affiliation_strings":["From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","General Practice, Offenbach/Main (A.S.), Germany","Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","institution_ids":["https://openalex.org/I155976169","https://openalex.org/I4210132578"]},{"raw_affiliation_string":"Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","institution_ids":[]},{"raw_affiliation_string":"General Practice, Offenbach/Main (A.S.), Germany","institution_ids":[]},{"raw_affiliation_string":"Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)","institution_ids":["https://openalex.org/I4210132578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112271917","display_name":"Norbert H. Rietbrock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]},{"id":"https://openalex.org/I4210132578","display_name":"University Hospital Frankfurt","ror":"https://ror.org/03f6n9m15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132578"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Norbert Rietbrock","raw_affiliation_strings":["From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","General Practice, Offenbach/Main (A.S.), Germany","Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Philipp Klee-Institute of Clinical Pharmacology, Hospital Wuppertal GmbH, Clinical Pharmacology, University Witten/Herdecke, Wuppertal (P.A.T.); Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.); Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.); and General Practice, Offenbach/Main (A.S.), Germany","institution_ids":["https://openalex.org/I155976169","https://openalex.org/I4210132578"]},{"raw_affiliation_string":"Department of Internal Medicine, Diakonissenkrankenhaus, Frankfurt (P.K.)","institution_ids":[]},{"raw_affiliation_string":"General Practice, Offenbach/Main (A.S.), Germany","institution_ids":[]},{"raw_affiliation_string":"Institute of Clinical Pharmacology, University Hospital, Frankfurt (S.H., N.R.)","institution_ids":["https://openalex.org/I4210132578"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":15.0124,"has_fulltext":true,"cited_by_count":207,"citation_normalized_percentile":{"value":0.99271791,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"98","issue":"19","first_page":"2037","last_page":"2042"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.6190999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.6190999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.3034999966621399,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.03869999945163727,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/left-ventricular-hypertrophy","display_name":"left ventricular hypertrophy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.9869999885559082},{"id":"https://openalex.org/keywords/angiotensin-ii-at1-receptor-antagonists","display_name":"angiotensin II AT1 receptor antagonists","score":0.9309999942779541},{"id":"https://openalex.org/keywords/atenolol","display_name":"atenolol","score":0.9819999933242798},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.8769999742507935},{"id":"https://openalex.org/keywords/left-ventricular-mass-index","display_name":"left ventricular mass index","score":0.9340000152587891},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.875},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/echocardiography","display_name":"echocardiography","score":0.6660000085830688},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.47099998593330383},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2776525901","wikidata":"https://www.wikidata.org/wiki/Q411325","display_name":"Atenolol","level":3,"score":0.9587072730064392},{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.9406709671020508},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9272770881652832},{"id":"https://openalex.org/C2776002628","wikidata":"https://www.wikidata.org/wiki/Q1628627","display_name":"Left ventricular hypertrophy","level":3,"score":0.8032323122024536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6874472498893738},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6847193837165833},{"id":"https://openalex.org/C2777097880","wikidata":"https://www.wikidata.org/wiki/Q988405","display_name":"Essential hypertension","level":3,"score":0.6474630832672119},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6471911668777466},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.5568324327468872},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.5176270604133606},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.44892922043800354},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33287501335144043},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1116723120212555}],"mesh":[{"descriptor_ui":"D000068756","descriptor_name":"Valsartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001262","descriptor_name":"Atenolol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004452","descriptor_name":"Echocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017379","descriptor_name":"Hypertrophy, Left Ventricular","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D017379","descriptor_name":"Hypertrophy, Left Ventricular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017379","descriptor_name":"Hypertrophy, Left Ventricular","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1161/01.cir.98.19.2037","doi":"https://doi.org/10.1161/01.cir.98.19.2037","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.98.19.2037","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:10441113","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10441113","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"},{"id":"pmid:9808602","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9808602","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W59685809","https://openalex.org/W373529691","https://openalex.org/W1521804991","https://openalex.org/W1769893219","https://openalex.org/W1964007161","https://openalex.org/W1964498945","https://openalex.org/W1966833073","https://openalex.org/W1967943229","https://openalex.org/W1972736384","https://openalex.org/W1975240757","https://openalex.org/W1996308457","https://openalex.org/W2003233586","https://openalex.org/W2011187155","https://openalex.org/W2023544056","https://openalex.org/W2031131109","https://openalex.org/W2031971366","https://openalex.org/W2031988153","https://openalex.org/W2035509880","https://openalex.org/W2036890726","https://openalex.org/W2037950148","https://openalex.org/W2042293234","https://openalex.org/W2044045435","https://openalex.org/W2045789221","https://openalex.org/W2050477993","https://openalex.org/W2058755393","https://openalex.org/W2061241932","https://openalex.org/W2061743585","https://openalex.org/W2062220292","https://openalex.org/W2096073058","https://openalex.org/W2100767767","https://openalex.org/W2106929179","https://openalex.org/W2107511879","https://openalex.org/W2107686400","https://openalex.org/W2109177794","https://openalex.org/W2128940069","https://openalex.org/W2139699853","https://openalex.org/W2142393775","https://openalex.org/W2158493435","https://openalex.org/W2323072331","https://openalex.org/W2334499091","https://openalex.org/W2415134208","https://openalex.org/W2416046634","https://openalex.org/W2476146300","https://openalex.org/W2767007075","https://openalex.org/W4236421691"],"related_works":["https://openalex.org/W2017816436","https://openalex.org/W2364308294","https://openalex.org/W2348430011","https://openalex.org/W2026925494","https://openalex.org/W2389264082","https://openalex.org/W2389381502","https://openalex.org/W2042475862","https://openalex.org/W2104081469","https://openalex.org/W2171549055","https://openalex.org/W2361514302"],"abstract_inverted_index":{"BACKGROUND:":[0],"Left":[1],"ventricular":[2,65],"hypertrophy":[3],"(LVH)":[4],"represents":[5],"an":[6,23],"independent":[7],"risk":[8,284],"factor":[9],"in":[10,71,76,223,230,257,271,281,291],"patients":[11,58,100,222,229,261],"with":[12,22,59,190,212,219,237,242,262],"essential":[13,263],"hypertension.":[14,264],"Because":[15],"reversal":[16],"of":[17,25,29,98,106,153,202,255,274,283],"LVH":[18,41,256],"may":[19,267],"be":[20,43,184,268,289],"associated":[21],"improvement":[24],"prognosis,":[26],"the":[27,86,224,231,243,278],"influence":[28],"new":[30],"antihypertensive":[31],"compounds,":[32],"such":[33],"as":[34],"angiotensin":[35,87,244],"II":[36,88,245],"AT1":[37],"receptor":[38],"antagonists,":[39],"on":[40],"should":[42],"determined.":[44],"METHODS":[45],"AND":[46],"RESULTS:":[47],"In":[48],"a":[49,133,252],"randomized,":[50],"double-blind":[51],"trial,":[52],"69":[53],"predominantly":[54,258],"previously":[55,259],"untreated":[56,260],"hypertensive":[57,275],"echocardiographically":[60],"proven":[61],"LVH,":[62],"ie,":[63],"left":[64],"mass":[66],"index":[67],"(LVMI)":[68],">134":[69],"g/m2":[70,75,116,140,158,165],"men":[72],"and":[73,161,192,214,227],">110":[74],"women":[77],"and/or":[78],"end-diastolic":[79],"septal":[80],"thickness":[81],">12":[82],"mm,":[83],"received":[84],"either":[85],"antagonist":[89,246],"valsartan":[90,107,160,191,213,225,247],"or":[91],"atenolol":[92,128,167,197,232],"for":[93,248],"8":[94,104,200,228,249],"months.":[95],"Echocardiographic":[96],"data":[97],"58":[99],"were":[101,181],"available.":[102],"After":[103,199],"months":[105,201,250],"treatment":[108,189,241],"(n=29),":[109,129],"LVMI":[110,130,154],"decreased":[111,131,207],"from":[112,136],"127+/-23":[113],"to":[114,122,132,138,145,156,163,172,183,208,215,288],"106+/-25":[115],"(ratio":[117],"[R]=0.83;":[118],"95%":[119,142],"CI,":[120,143,170],"0.79":[121],"0.87;":[123],"P<0.0001":[124],"versus":[125,148,174],"baseline).":[126,149],"Under":[127],"smaller":[134],"extent,":[135],"127+/-25":[137],"117+/-27":[139],"(R=0.92;":[141],"0.86":[144],"0.98;":[146],"P=0.0082":[147],"The":[150,265],"mean":[151,177,204],"reduction":[152,285],"came":[155],"21":[157],"under":[159,166],"only":[162],"10":[164],"(R=0.91;":[168],"90%":[169],"0.85":[171],"0.97":[173],"atenolol).":[175],"Baseline":[176],"blood":[178,205],"pressure":[179,206],"values":[180],"determined":[182],"163+/-12/101+/-6":[185],"mm":[186,194,210,217],"Hg":[187,195,211,218],"before":[188,196],"160+/-14/103+/-6":[193],"treatment.":[198],"treatment,":[203],"146+/-13/90+/-7":[209],"147+/-18/90+/-7":[216],"atenolol.":[220],"Nine":[221],"group":[226,233],"required":[234],"additional":[235],"medication":[236],"hydrochlorothiazide.":[238],"CONCLUSIONS:":[239],"Antihypertensive":[240],"produced":[251],"significant":[253],"regression":[254],"drug":[266],"safely":[269],"administered":[270],"this":[272],"subset":[273],"patients;":[276],"however,":[277],"long-term":[279],"benefit":[280],"terms":[282],"has":[286],"still":[287],"evaluated":[290],"further":[292],"trials.":[293]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2093934591","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
